Aurora’s River production facility in Bradford, Ontario, has received European Union Good Manufacturing Practice certification, the cannabis company announced on Monday.
In addition to the EU GMP certification, Aurora said that German regulators have given their approval to restart sales following a December 2019 suspension on certain products.
The EU GMP certification is required to export medical cannabis products into most European markets.
Aurora said it will fulfil existing orders from inventory held in Germany. Local pharmacies have been instructed to begin selling Aurora products once again, the company said.
The EU GMP certification of the Bradford site gives Aurora three such licensed facilities in Canada; the others being ground in Mountain View County, Alberta and Markham, Ontario.
Aurora has 10 licensed facilities in Canada altogether, with Aurora River facility built to accommodate large-scale production. It has 17 grow rooms capable of producing up to 28,000 kg per year.
The GMP certification allows the company to allot additional dried flower and extracted products to the worldwide market, and the company said it will increase international medical market production capacity by 230%.
“The EU GMP certification of our River facility further validates our strategy focused on purpose-built facilities, designed and constructed exclusively for the production of high-quality, pharmaceutical grade cannabis,” CEO Terry Booth said in a statement.
